Chemical carcinogens are generally activated enzymatkally to electrophiles that form covalently bound carcinogen-DNA adducts. Detoxifying enzymes are competing with the activating enzymes for these procarcinogenic chemical substrates. Wide person-to-person variations in these two types of enzymatic activities are found. Repair rates of DNA damage caused by carcinogens also vary among individuals. These interindividual differences in the metabolism of chemical carcinogens and repair rates of carcinogen-induced DNA damage reflect acquired and inherited host factors that may influence an individual's risk for development of cancer.
Introduction
'No one supposes that all the individuals of the same species are cast in the very same mould. These individual differences are highly important for us...' (Charles Darwin, The Origin of Species, 1859).
Scientists have repeatedly recognized person-to-person differences in behavior, morphology and risk of disease. Such interindividual differences may be either acquired or inherited. For example, inherited differences in susceptibility to physical or chemical carcinogens have been observed among individuals, including an increased risk of sunlight-induced skin cancer in people with xeroderma pigmentosum (1), bladder cancer in dye stuff workers with a poor acetylator phenotype (2) and bronchogenie carcinoma in tobacco smokers, who have an extensive debrisoquine hydroxylator phenotype (3) .
Carcinogenesis is a multistage process involving both genetic and epigenetic changes in the progenitor cells of cancer ( Figure 1 ) (4) (5) (6) (7) . Because most chemical carcinogens require metabolic activation to exert their oncogenic effects and the amount of ultimate carcinogen produced results from the action of competing activation and detoxication pathways, interindividual variation in carcinogen metabolism is considered to be an important determinant of cancer susceptibility. DNA adducts are one form of genetic damage caused by chemical carcinogens and may lead to mutations that activate proto-oncogenes and inactivate tumor suppressor genes in replicating cells. The steady-state levels of these adducts depend on both the amount of ultimate carcinogens available and the rate of removal from DNA by enzymatic repair processes. The genomic distribution of adduct formation and repair is both nonrandom and influenced by both DNA sequence and chromatin structure (8 -11) .
This brief commentary will focus on acquired and inherited differences among individuals in both metabolism of chemical carcinogens and DNA repair rates. The data have largely been generated using in vitro models of human tissues, cells or dieir
•Abbreviations: AHH, aryl hydrocarbon hydroxylase; RFLP, fragment length polymorphism. subcellular components (7) . Associations between interindividual variations in these enzymatic activities and cancer susceptibility will be emphasized. Carcinogen metabolism and DNA adduct formation Chemical carcinogens are metabolized by a wide variety of cytosolic and microsomal enzymes. Multiple forms of human cytochrome P-450 are involved in the oxidative metabolism of chemical carcinogens, e.g. polycyclic aromatic hydrocarbons (12) . Several thousand-fold interindividual variation has been observed in placental aryl hydrocarbon hydroxylase (AHH*) activity; some of this variability is under direct genetic control, but variations are also the result of an enzyme induction process due to maternal exposure to environmental carcinogens, e.g. tobacco smoke or dietary factors (13) (14) (15) . However, the induction process itself may have a genetic component (16) and inducible AHH activity is higher in cultured lymphocytes from lung cancer cases when compared with controls (17). Trell and coworkers (18) are currently conducting a prospective study to determine if high inducibility of AHH is a risk factor for the development of cancer. Increased binding of benzo[a]pyrene metabolites to DNA in lymphocytes of patients with lung cancer versus non-cancer controls has also been observed (19) .
Cytochrome P-45Odbl activity is polymorphic and has also been linked to lung cancer risk (3). This P^50 hydroxylates xenobiotics, e.g. debrisoquine, and an individual's polymorphic phenotype is inherited in an autosomal recessive manner. The 4-hydroxylation of debrisoquine varies several thousand-fold among people, and lung, liver or advanced bladder cancer patients are more likely to have the extensive hydroxylator phenotype when compared with non-cancer controls (3, 20, 21) . Although it is attractive to speculate that P-450dbl may activate a chemical carcinogen(s) found in tobacco smoke, thereby rendering an individual with the extensive metabolizor phenotype at greater risk, carcinogenic substrates for this cytochrome P-450dbl have not as yet been identified. An alternative hypothesis is that the P-450dbl gene is in linkage disequilibrium with a different gene that does influence cancer susceptibility.
The N-acetylation polymorphism is controlled by two autosomal alleles at a single locus in which rapid acetylation is the dominant trait and slow acetylation is recessive. Acetylation of carcinogenic aromatic amines has been proposed as a cancer risk factor. The slow acetylator phenotype has been linked to occupationally induced bladder cancer in dye workers exposed to large amounts of N-substituted aryl compounds (2) . Interestingly, die rapid acetylator phenotype is commonly found in colon cancer cases (22) . Whether or not this linkage is due to metabolism of a carcinogenic aromatic amine in the colonic epithelium is not known.
Wide interindividual differences in detoxifying enzymes of carcinogens are also found. For example, at each step in the metabolic pathway of benzo their activities (23) . Indirect evidence was also presented that tobacco smoking induced several of these enzymes. Genetic control of the presumed detoxication of benzo[a]pyrene by conversion to water-soluble metabolites has been reported (16) . Metabolism of carcinogens from several chemical classes, including N-nitrosamines, polycyclic aromatic hydrocarbons, hydrazines, mycotoxins and aromatic amines, has been studied in cultured human tissues and cells (24) (25) (26) (27) (28) (29) (30) (31) . The enzymes responsible for the activation and deactivation of procarcinogens, the metabolites produced, and the carcinogen-DNA adducts formed by cultured human tissues and cells, in general, are qualitatively similar among donors and tissue types. The DNA adducts and carcinogen metabolites are also similar to those found in most laboratory animals, an observation that supports the qualitative extrapolation of carcinogenesis data from the laboratory animal to the human. Some notable differences among animal species have been reported, including metabolism of aromatic amines in the guinea pig (32), benzo[a]pyrene in the rat (33) and aflatoxin B[ in the Syrian golden hamster (34) .
Although the major DNA adducts are qualitatively similar for the chemical carcinogens so far studied in these in vitro models, quantitative differences have been found among individuals and their various tissue types (28, 30, (35) (36) (37) . The differences in formation of DNA adducts range from ~ 10-to 150-fold among humans, the interindividual distribution is generally unimodal, and the variation is similar in magnitude to that found in pharmacogenetic studies of drug metabolism.
DNA repair rates DNA repair enzymes modify DNA damage caused by carcinogens, including removal of DNA adducts. Studies of cells from donors with xeroderma pigmentosum have been particularly 1564 important in expanding our understanding of DNA excision repair and its possible relationship to risk of cancer (1). The rate but not the fidelity of DNA repair can be determined by measuring unscheduled DNA synthesis and removal of DNA adducts, and substantial interindividual variations in DNA repair rates have been observed (38) . In addition to rinding excision repair rates severely depressed in xeroderma pigmentosum cells (e.g. complimentation group A), an ~ 5-fold variation among individuals in unscheduled DNA synthesis induced by UV exposure of lymphocytes in vitro has been found in the general population (38) . A significant reduction in unscheduled DNA synthesis induced in vitro by N-acetoxy-2-acetylaminofluorene has been observed in mononuclear leukocytes from individuals with a history of cancer in first-degree relatives when compared with those without a family history (39, 40) .
Interindividual variation has been noted in the activity of O^-alkylguanine-DNA alkyltransferase; this enzyme repairs alkylation damage to C^-deoxyguanine (41 -44) . In addition to these person-to-person differences, wide variations in DNA repair activities have been observed in different types of tissue (41, 42, 45, 46) , and fetal tissues exhibit 2-to 5-fold less activity than the corresponding adult tissue (47) , and cells may have lower repair rates after terminal differentiation (48) . The activity of this DNA repair enzyme is inhibited by certain aldehydes (45) and alkylating cancer chemotherapeutic agents (49) . Decreased activity of this DNA repair activity has been observed in fibroblasts from patients with lung cancer when compared with donors with either melanoma or noncancer controls (50) . Therefore, acquired and/or inherited deficiency in C^-alkylguanine-DNA-alkyltransferase may be a cancer risk factor in tobacco smokers.
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Carcinogen metabolism, DNA adduct formation and DNA repair expoxide-DNA adducts has been observed using human lymphocytes in vitro (51) . The interindividual variation was substantially greater than the intraindividual variation which suggests the influence of inherited factors. The influence of these variations in DNA repair rates in determinng tissue site and risk of cancer in the general population remains to be determined.
Future studies
The interindividual variations found in carcinogen metabolism, DNA adduct formation and DNA repair rates are influenced by a complex interaction between acquired and inherited host factors. Therefore, the contribution of inheritance to these activities and their importance in cancer susceptibility is difficult to determine. However, rapid advances are being made in (i) cloning the cytochrome P-450 genes involved in carcinogen metabolism; (ii) determining the molecular control of their expression by positive and negative regulatory elements, that may be constitutive as well as inducible; (iii) defining mutations, e.g. deletions involved in genetic polymorphism; (iv) isolation of their gene products; and (v) the development of immunoassays to measure them (12) . More than 15 types of human P-450 have been genetically cloned (12) . In one case, i.e. P-450dbl, DNA restriction fragment length polymorphism (RFLP) analysis can be used to identify ~75% of the individuals with the poor hydroxylator phenotype (52) . Investigators are searching for RFLPs that are predictive of oxidative propensity of the various forms of the P-450 in the multigene family so that an individual's phenotype can be tested at the DNA level without the current necessity to administer xenobiotics to people. If this approach proves to be feasible, an individual could be genotyped by RFLP analysis in utero or at birth and, if necessary, additional steps could be taken to prevent exposure to certain chemicals and to utilize other types of intervention. Efforts to clone DNA repair genes have proven to be difficult in part because of the complex nature of these genes. For example, the human DNA repair gene, ERCC-1, is an evolutionary composite of the uvr A and C genes found in bacteria and rad 10 gene found in yeast (53) . As human DNA repair genes are isolated, the fidelity of these enzymes in the repair process can be determined and more specific and rapid assays can be developed so that the role of interindividual variation in DNA repair during chemical carcinogenesis can be better understood.
The primary goal of molecular epidemiology is to identify individuals at increased cancer risk by obtaining evidence of high exposure to carcinogens, leading to pathobiological lesions in target cells, and/or increased oncogenic susceptibility due to either inherited or acquired host factors. This multidisciplinary area of cancer research combines epidemiological and laboratory approaches (54, 55) . Interindividual variations among humans in carcinogen biodistribution and metabolism, DNA adduct formation and DNA repair have important implications in molecular epidemiology of cancer risk. An increased understanding of the molecular basis of these differences among humans and their linkage with critical steps in carcinogenesis may afford in the future the potential to predict disease risk for individual persons, instead of populations, and before the onset of clinically evident disease.
'In biology, one rarely deals with classes of identical entities, but nearly always studies populations consisting of unique individuals. This is true for every level of hierarchy, from cells to ecosystems' (Ernst Mayr, The Growth of Biological Thought, 1982) .
